title: [Initial or interval debulking surgery for advanced stage ovarian cancer: state-of-the-art. How to select patients?].
abstract: The management of advanced stage ovarian cancer has been deeply modified over the last few years. In patients with massive peritoneal spread, the use of neoadjuvant chemotherapy, followed by interval surgery, reduces the morbidity of radical surgery with an improvement of the quality of life. Nevertheless, results of ongoing randomized studies should be waited before stating about the results on survival of such management compared to initial debulking surgery. Waiting such results, the standard treatment of advanced stage ovarian cancer in 2005 remains initial surgery, performed in order to obtain ideally a total resection of all macroscopic diseases, and followed by adjuvant chemotherapy. However, in patients with massive spread, interval debulking surgery is becoming an interesting option, and will perhaps become a standard management. But criteria to select patients between initial and interval debulking surgery should be clearly defined. Those different points will be studied in this paper.
authors.affiliation: Service de chirurgie, institut Gustave-Roussy, 39, rue Camille-Desmoulins, 94805 Villejuif cedex, France. morice@igr.fr
authors.forename: P
authors.initials: P
authors.lastname: Morice
authors.forename: E
authors.initials: E
authors.lastname: Leblanc
authors.forename: F
authors.initials: F
authors.lastname: Narducci
authors.forename: C
authors.initials: C
authors.lastname: Pomel
authors.forename: P
authors.initials: P
authors.lastname: Pautier
authors.forename: A
authors.initials: A
authors.lastname: Chevalier
authors.forename: C
authors.initials: C
authors.lastname: Lhommé
authors.forename: D
authors.initials: D
authors.lastname: Castaigne
mesh_terms: D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D010535:Laparoscopy; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000473:pathology / Q000601:surgery*; D018579:Patient Selection